Adam S. Grossman, President and CEO at ADMA BIOLOGICS, INC. (ADMA), bought 485,000 shares at $2.15 ($1.0M) on 2017-11-09, disclosed to the SEC on 2017-11-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| ADMA | SELL | 2025-12-16 | $416K | — | Filing → |
| ADMA | SELL | 2025-11-21 | $336K | — | Filing → |
| ADMA | SELL | 2025-10-24 | $336K | — | Filing → |